What is JuneBrain?
JuneBrain Inc. operates at the vanguard of medical technology, specializing in the development of telehealth Optical Coherence Tomography (OCT) devices integrated with sophisticated AI software. The company addresses a significant gap in the healthcare market by facilitating the remote monitoring of complex neurological and retinal conditions. By providing portable, user-friendly hardware, JuneBrain empowers clinicians to conduct high-fidelity diagnostics outside of traditional hospital settings, thereby streamlining clinical trials and improving patient access to specialized care. As a recognized women-owned small business, the firm maintains a strategic focus on diversity and technical excellence, positioning itself as a key player in the digital health ecosystem.
How much funding has JuneBrain raised?
JuneBrain has raised a total of $600K across 2 funding rounds:
Unspecified
$150K
Stock/Share Issuance
$450K
Unspecified (2023): $150K with participation from TEDCO Business Support
Stock/Share Issuance (2025): $450K, investors not publicly disclosed
Key Investors in JuneBrain
TEDCO Business Support
TEDCO provides business support services specializing in assisting individuals and enterprises to start, grow, and secure capital for their ventures.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for JuneBrain?
Looking ahead, the strategic deployment of the $450K will likely focus on the commercialization of its core OCT platform and the expansion of its AI-driven diagnostic suite. The company is expected to prioritize regulatory milestones and the scaling of its point-of-care distribution networks. By optimizing its remote monitoring capabilities, JuneBrain aims to solidify its market position as an essential partner for neurology and ophthalmology practices globally. Future growth will likely be driven by the integration of its software into broader telehealth infrastructures, ensuring that advanced eye and brain health monitoring becomes a standard component of modern patient care.
See full JuneBrain company page